B Lymphocytes and Antibody-Mediated Immunity
Introduction
B lymphocytes and their antibody products are central to humoral immunity, providing protection against extracellular pathogens and toxins. In dermatology, antibodies play critical pathogenic roles in autoimmune blistering diseases, connective tissue disorders, and allergic conditions, while also serving as essential diagnostic tools and therapeutic agents.
This chapter explores B cell biology, antibody structure and function, and their roles in skin health and disease.
B Cell Development and Activation
B Cell Maturation
Loading diagram...
B Cell Activation: T-Dependent Response
Loading diagram...
Antibody Structure and Classes
Immunoglobulin Structure
Loading diagram...
Immunoglobulin Classes
| Class | Structure | Location | Function | Skin Relevance |
|---|
| IgG | Monomer | Blood, tissues | Opsonization, complement, ADCC, placental transfer | Most autoantibodies (pemphigus, pemphigoid) |
| IgA | Dimer (secretory) | Mucosal surfaces, secretions | Mucosal immunity | IgA pemphigus, HSP (IgA vasculitis) |
| IgM | Pentamer | Blood | Early response, complement activation | Cold agglutinins, cryoglobulins |
| IgE | Monomer | Bound to mast cells | Allergy, parasites | Atopic dermatitis, urticaria |
| IgD | Monomer | B cell surface | B cell activation | Limited clinical role |
IgG Subclasses
| Subclass | % of Total | Complement | FcγR Binding | Disease Examples |
|---|
| IgG1 | 60-70% | +++ | Strong | Pemphigus vulgaris |
| IgG2 | 20-30% | + | Weak | Anti-carbohydrate |
| IgG3 | 5-8% | ++++ | Strong | Highest complement |
| IgG4 | 1-4% | − | Weak | Pemphigus foliaceus, IgG4-RD |
Antibody Effector Functions
Mechanisms of Antibody Action
Loading diagram...
Fcγ Receptors
| Receptor | Cells | Affinity | Function |
|---|
| FcγRI (CD64) | Macrophages, DCs | High | Phagocytosis |
| FcγRIIA (CD32a) | Neutrophils, macrophages | Low | Phagocytosis |
| FcγRIIB (CD32b) | B cells | Low | Inhibitory |
| FcγRIII (CD16) | NK cells, macrophages | Low | ADCC |
| FcRn | Endothelium, epithelium | pH-dependent | IgG recycling |
Autoantibodies in Dermatology
Autoimmune Blistering Diseases
Loading diagram...
Key Autoantibodies in Skin Disease
| Disease | Target Antigen | Antibody Class | Detection |
|---|
| Pemphigus vulgaris | Desmoglein 3 (± Dsg1) | IgG | DIF: intercellular IgG/C3 |
| Pemphigus foliaceus | Desmoglein 1 | IgG (often IgG4) | DIF: intercellular IgG |
| Bullous pemphigoid | BP180 (NC16A), BP230 | IgG | DIF: linear BMZ IgG/C3 |
| Epidermolysis bullosa acquisita | Type VII collagen | IgG | DIF: linear BMZ IgG |
| Dermatitis herpetiformis | Epidermal transglutaminase | IgA | DIF: granular IgA at dermal papillae |
| Linear IgA disease | BP180 (LAD-1) | IgA | DIF: linear BMZ IgA |
| Systemic lupus | dsDNA, Sm, SSA/Ro | IgG | ANA, specific antibodies |
| Dermatomyositis | Mi-2, MDA5, NXP-2, TIF1-γ | IgG | Myositis-specific antibodies |
Desmoglein Compensation Theory
Loading diagram...
IgE and Allergic Disease
IgE Pathway
Loading diagram...
IgE in Skin Disease
| Condition | IgE Role | Clinical Features |
|---|
| Atopic dermatitis | Elevated total IgE | Allergen-specific IgE, skin barrier dysfunction |
| Chronic urticaria (some) | Anti-FcεRI or anti-IgE autoantibodies | Autoimmune urticaria |
| Anaphylaxis | IgE-mediated mast cell degranulation | Systemic reaction |
| Allergic contact dermatitis | Minimal role | T cell mediated (not IgE) |
| Drug reactions | Some IgE-mediated | Penicillin, β-lactams |
B Cells in Skin Disease
B Cell Infiltrates in Skin
| Disease | B Cell Role | Histology |
|---|
| Cutaneous lymphoid hyperplasia | Polyclonal B cell expansion | Lymphoid follicles |
| Primary cutaneous B cell lymphomas | Malignant B cells | MZL, FCL, DLBCL |
| Lupus | Autoantibody production | Interface dermatitis |
| Dermatomyositis | Autoantibody production | Perivascular inflammation |
| Morphea | Possible role | Sclerosis with inflammation |
B Cell Therapies
| Agent | Mechanism | Indications |
|---|
| Rituximab | Anti-CD20 (B cell depletion) | Pemphigus, pemphigoid, CTCL, lupus |
| Omalizumab | Anti-IgE | Chronic urticaria, severe atopic |
| Belimumab | Anti-BAFF | Lupus |
| IVIG | Multiple (FcRn, Fc receptor saturation) | Toxic epidermal necrolysis, autoimmune blistering |
Laboratory Evaluation
Antibody Detection Methods
Loading diagram...
Salt-Split Skin Technique
For subepidermal blistering:
| Pattern | Interpretation | Diseases |
|---|
| Epidermal (roof) | Hemidesmosome antigens | BP, LABD, Cicatricial pemphigoid |
| Dermal (floor) | Basement membrane zone | EBA, Anti-laminin-332 |
| Combined | Multiple targets | Mixed features |
Summary
Loading diagram...
Key Clinical Pearls
| Topic | Pearl |
|---|
| Pemphigus diagnosis | DIF > indirect IF; intercellular ("chicken-wire") IgG |
| BP vs EBA | Salt-split skin: BP = roof, EBA = floor |
| IgG4 | Low complement activation; predominates in pemphigus foliaceus |
| Omalizumab | Anti-IgE; effective in chronic urticaria regardless of IgE level |
| Rituximab | First-line in pemphigus; may take months for effect |
| Desmoglein antibodies | ELISA titers correlate with disease activity |
Cross-References
How to Cite
Cutisight. "B Lymphocytes Antibodies." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-03-skin-reactions-and-interactions/04-immunology/02-adaptive-immunity/03-humoral-immunity/01-b-lymphocytes-antibodies
This is an open-access resource. Please cite appropriately when using in academic or clinical work.